Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
53.78
-3.76 (-6.53%)
Mar 5, 2026, 4:00 PM EST - Market closed
Spruce Biosciences Employees
Spruce Biosciences had 21 employees as of December 31, 2024. The number of employees decreased by 8 or -27.59% compared to the previous year.
Employees
21
Change (1Y)
-8
Growth (1Y)
-27.59%
Revenue / Employee
$77,444
Profits / Employee
-$5,319,889
Market Cap
57.56M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| TScan Therapeutics | 148 |
| Metagenomi Therapeutics | 124 |
| ImmuCell | 84 |
| InflaRx | 74 |
| Rallybio | 15 |
| Instil Bio | 14 |
| MAIA Biotechnology | 13 |
| Alterity Therapeutics | 9 |
SPRB News
- 3 days ago - Spruce Biosciences to Present at Upcoming Investor Conferences in March - Business Wire
- 16 days ago - Spruce Biosciences Announces Positive Type B Meetings with U.S. FDA for TA-ERT for the Treatment of Sanfilippo Syndrome Type B (MPS IIIB) - Business Wire
- 16 days ago - Spruce Biosciences to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference - Business Wire
- 4 weeks ago - Long-Term Data Presented at the 22nd Annual WORLDSymposium™ Highlights Tralesinidase Alfa Enzyme Replacement Therapy's Potential as the First Disease-Modifying Treatment Option for Sanfilippo Syndrome Type B (MPS IIIB) - Business Wire
- 4 weeks ago - Spruce Biosciences Adds Regulatory and Clinical Development Expertise to Leadership Team - Business Wire
- 5 weeks ago - Spruce Biosciences Announces Data Presentations at the 22nd Annual WORLDSymposium™ - Business Wire
- 6 weeks ago - Harbour BioMed Acquires Common Stock in Spruce Biosciences, Deepening Strategic Collaboration - PRNewsWire
- 2 months ago - Spruce Biosciences Secures Up to $50 Million in Growth Capital from Avenue Capital - Business Wire